Sunday, July 3, 2022
  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services
Janam TV English
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
Janam TV English
No Result
View All Result
  • News
  • Business
  • Defence
  • Health
Home Business

Dr. Reddy’s Lab announces commercial launch of anti-covid drug 2DG

by Janam Web Desk
Jun 28, 2021, 04:58 pm IST
in Business, Health

Hyderabad, Jun 28 (UNI):   Dr. Reddy’s Laboratories Limited, on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), anti-Covid drug.

With Maximum Retail Price (MRP) of each sachet fixed at Rs 990, the drug will be supplied to major Governments as well as private hospitals across the country, Hyderabad based Pharmaceutical giant Dr Reddy Labs said in a release here.

In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India and with a subsidized rate offered to Government Institutions.

2-DG manufactured by Dr. Reddy’s has a purity of 99.5 per cent and is being sold commercially under the brand name 2DGTM.

2-DG, an oral drug, was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s.

It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe COVID-19 patients as an adjunct therapy to the existing standard of care.

Emergency use approval for anti-COVID-19 therapeutic application of the drug was granted on May 1, 2021.

Tags: oral drugMAINFEATUREDcovid 19 India2-DGDr Reddy's Labs
Share1TweetSendShare

Related News

Udaipur beheading case; Two Islamic terrorists arrested for conspiracy
News

Udaipur beheading case; Two Islamic terrorists arrested for conspiracy

Gold smuggling case; Swapna Suresh appeared before ED
News

Gold smuggling case; Swapna Suresh appeared before ED

Eknath Shinde sworn in as Maharashtra CM; Devendra Fadnavis Deputy CM
News

Eknath Shinde sworn in as Maharashtra CM; Devendra Fadnavis Deputy CM

Latest News

BJP era for next 40 years; India will become the Vishwa Guru, Amit Shah

BJP era for next 40 years; India will become the Vishwa Guru, Amit Shah

Chinese company shuts down its plant in India: Dismissed employees, Great Wall Motors

Chinese company shuts down its plant in India: Dismissed employees, Great Wall Motors

PM’s letter to Mithali: She said it is a proud moment

PM’s letter to Mithali: She said it is a proud moment

Maharashtra: BJP proves majority; Rahul Narwekar sworn in as the speaker

Maharashtra: BJP proves majority; Rahul Narwekar sworn in as the speaker

Leaked information for Pakistan: 3 youngsters arrested

Leaked information for Pakistan: 3 youngsters arrested

Kerala: Communicable fever rises; 30,000 patients in 2 days

Kerala: Communicable fever rises; 30,000 patients in 2 days

Investment promotion: Sri Lanka to give 5 year visa to Indian business giants

Investment promotion: Sri Lanka to give 5 year visa to Indian business giants

INS Vikrant again for sea trials; this is the 4th stage; soon be a part of the Indian Navy

INS Vikrant again for sea trials; this is the 4th stage; soon be a part of the Indian Navy

  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services

© Janam Multimedia Limited

No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto

© Janam Multimedia Limited